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long-term macrolide use, to allow us to target these 
drugs more eﬀ ectively in terms of risks and beneﬁ t. 
What risks might be posed both for individual patients 
and for society by the eﬀ ects of macrolides on microbial 
selection is unclear, especially when they are used 
for more prevalent disorders such as COPD. We must 
remember the dictum to ﬁ rst do no harm, and proceed 
with caution.
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Can the internet help economically disadvantaged smokers? 
Smoking is a major contributor to health inequalities 
between diﬀ erent social groups in many countries.1 For 
example, smoking is responsible for roughly half the 
total number of deaths in economically disadvantaged 
men aged 35–69 years in the US and the UK.2 However, 
little evidence exists for strategies to reduce smoking-
related health disparities.3 Mainstream smoking 
cessation strategies are consistently reported to have 
poorer eﬀ ectiveness in economically disadvantaged 
smokers than in aﬄ  uent smokers.3 Furthermore, 
internet-based cessation strategies have additional 
concerns regarding eﬀ ectiveness in smokers with poor 
educational attainment because these individuals 
are less likely to engage with web-based programs 
than are those with high attainment. In The Lancet 
Respiratory Medicine, Jamie Brown and colleagues’ 
randomised controlled trial4 challenges the prevailing 
position on the value of smoking cessation as a pro-
equity approach.
With an aim to assess the eﬀ ectiveness of 
StopAdvisor—an interactive internet-based inter-
vention in smokers of high and low socioeconomic 
status—4613 participants were randomly allocated to 
the StopAdvisor intervention or to an information-
only website (control). The primary outcome was 
biochemically veriﬁ ed 6-month continuous smoking 
abstinence. Rates of overall continuous smoking 
abstinence were similar between participants in the 
StopAdvisor and control groups (237 [10%] of 2321 
vs 220 [10%] of 2292 participants; relative risk [RR] 
1·06, 95% CI 0·89–1·27; p=0·49). However, there 
were diﬀ erences in the intervention eﬀ ect across 
high and low socioeconomic status subsamples (RR 
1·44, 95% CI 0·99–2·09; p=0·0562). Participants with 
low socioeconomic status achieved higher cessation 
rates with StopAdvisor than with the information-
only website (90 [8%] of 1088 vs 64 [6%] of 1054 
participants; RR 1·36, 95% CI 1·00–1·86; p=0·0499), 
but no diﬀ erence was noted in those with high 
socioeconomic status (147 [12%] of 1233 vs 156 [13%] 
of 1238 participants; 0·95, 0·77–1·17; p=0·61). The 
investigators conclude that although StopAdvisor 
might not help aﬄ  uent smokers, it is likely to beneﬁ t 
those who are economically disadvantaged.
The StopAdvisor intervention is based on behaviour-
change theory and was developed iteratively after 
being piloted in economically disadvantaged smokers. 
Most trial participants had no previous exposure to 
behavioural support, conﬁ rming the investigators’ 
assumption that internet-based cessation is likely to 
reach treatment-naive smokers. Participant charac-
teristics were balanced across the two groups and 
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sample size was suﬃ  cient to assess eﬀ ectiveness in 
both socioeconomic status subgroups. However, 
trial participants were recruited directly from the 
internet in a high-income country, hence the cohort 
included only economically disadvantaged smokers 
who had access to internet. Findings cannot be 
extrapolated to countries where access and internet 
literacy might diﬀ er from that in the UK. Although the 
StopAdvisor intervention seems to beneﬁ t smokers 
of low socioeconomic status, their quit rates in the 
intervention group remained lower compared with 
those noted in either intervention or control group 
in the high socioeconomic status subgroup. This 
ﬁ nding is not unexpected, but a stark reminder of 
the challenges faced by economically disadvantaged 
smokers in quitting. 
Findings from the StopAdvisor trial are consistent 
with a Cochrane review of internet-based cessation.5 
However, none of the 28 studies included in that 
review reported any subgroup analyses based on 
socioeconomic status. The overall low eﬀ ectiveness of 
StopAdvisor is consistent with studies that compared 
internet-based cessation with active controls (ie, 
more intensive than self-help or usual care). On the 
other hand, the eﬀ ect in economically disadvantaged 
smokers in the StopAdvisor trial, is consistent with 
studies that included tailoring and interactivity in 
their interventions and that made comparisons with 
inactive controls (self-help and usual care). At best, 
an internet-based intervention such as StopAdvisor 
might achieve better cessation rates than usual care 
or self-help,6 similar to rates with face-to-face or 
telephone-based behavioural support,7 but inferior to 
those achieved by combining drugs with behavioural 
support.8
Despite their modest eﬀ ect, internet-based 
approaches have a distinct appeal because of their low 
cost and potential to be used by smokers who would 
otherwise have no access to behavioural support or 
drugs. About 95% of smokers in low-income and 
middle-income countries fall in the above category. 
Even in high-income countries, such as the USA, 
only a third of smokers report use of behavioural 
support or drugs to help quit, possibly because of 
restricted access.9 Digital divide—ie, inequality in 
access and use of internet-like technologies between 
diﬀ erent social strata—could be a barrier to use of 
such approaches.10 However, internet access and 
literacy is likely to improve as the internet becomes 
increasingly recognised as a way to improve economic 
opportunities and reduce inequalities. Further 
research is needed to assess the uptake and long-term 
eﬀ ectiveness of internet-based cessation in not only 
economically disadvantaged groups, but also in those 
who are marginalised for other reasons.
Tailor-made internet-based interventions with an 
interactive component might beneﬁ t economically 
disadvantaged smokers who have access to internet 
and are computer literate. More studies are needed to 
conﬁ rm this assertion in diﬀ erent contexts. The eﬀ ect 
of such interventions is likely to be marginal compared 
with face-to-face support and drugs oﬀ ered by 
cessation advisors. However, considering their relatively 
low-cost, internet-based approaches are appealing, 
especially if access to internet and computer literacy 
widens to cover all sections of society.
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